Get started
Inozyme Pharma, Inc.Inozyme Pharma, Inc.Inozyme Pharma, Inc.

Inozyme Pharma, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

INZY chart

Key stats

Market capitalization
‪271.18 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.39USD
Net income
‪−71.17 M‬USD
Revenue
—
Shares float
‪41.14 M‬
Beta (1Y)
2.32

About Inozyme Pharma, Inc.

Sector
Health Technology
CEO
Douglas A. Treco
Headquarters
Boston
Website
inozyme.com
Employees (FY)
59
Founded
2015
FIGI
BBG00J7QJMC1
Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company was founded by Axel Bolte, Joseph P. Schlessinger, and Demetrios T. Braddock in September 2015 and is headquartered in Boston, MA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of INZY is 4.40 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Inozyme Pharma, Inc. stocks are traded under the ticker INZY.
Inozyme Pharma, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
INZY stock is 3.20% volatile and has beta coefficient of 2.32. Check out the list of the most volatile stocks — is Inozyme Pharma, Inc. there?
INZY earnings for the last quarter are −0.29 USD per share, whereas the estimation was −0.32 USD resulting in a 8.56% surprise. The estimated earnings for the next quarter are −0.32 USD per share. See more details about Inozyme Pharma, Inc. earnings.
Yes, you can track Inozyme Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
INZY stock has fallen by 10.57% compared to the previous week, the month change is a 24.79% fall, over the last year Inozyme Pharma, Inc. has showed a 24.40% decrease.
INZY net income for the last quarter is ‪−21.54 M‬ USD, while the quarter before that showed ‪−16.64 M‬ USD of net income which accounts for −29.49% change. Track more Inozyme Pharma, Inc. financial stats to get the full picture.
Today Inozyme Pharma, Inc. has the market capitalization of ‪271.80 M‬, it has decreased by 9.48% over the last week.
No, INZY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, INZY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Inozyme Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
INZY reached its all-time high on Aug 24, 2020 with the price of 31.65 USD, and its all-time low was 0.99 USD and was reached on Dec 30, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 59.00 employees. See our rating of the largest employees — is Inozyme Pharma, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Inozyme Pharma, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Inozyme Pharma, Inc. stock shows the sell signal. See more of Inozyme Pharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Inozyme Pharma, Inc. future price: according to them, INZY price has a max estimate of 40.00 USD and a min estimate of 14.00 USD. Read a more detailed Inozyme Pharma, Inc. forecast: see what analysts think of Inozyme Pharma, Inc. and suggest that you do with its stocks.